A Study of the Safety and Tolerability of GA in the Treatment of Patients With Refractory Neuropathic Pain

Clinical trial NCT06596681 · RECRUITING

Trial details

NCT number: NCT06596681
Sponsor: Beijing Tiantan Hospital
Status: RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

Pain, Intractable

Start date: 2024-09-11
Primary completion: 2026-12-31
Enrollment: 6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.